Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review

In comparison to the general population, lung cancer patients are more likely to suffer from severe Coronavirus disease (COVID-19) and associated mortality. Considering this increased risk, and in order to prevent symptoms and severe disease, patients with lung cancer have been prioritized for COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodilla, Ananda M., Tavolacci, Sooyun, Cagan, Jazz, Shah, Tanay, Mittan, Sandeep, Mack, Philip C., Hirsch, Fred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223259/
https://www.ncbi.nlm.nih.gov/pubmed/37243073
http://dx.doi.org/10.3390/vaccines11050969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223259/
https://www.ncbi.nlm.nih.gov/pubmed/37243073
http://dx.doi.org/10.3390/vaccines11050969

Ejemplares similares